Watson Pharmaceuticals, Inc. (WPI) Income Statement

Click line-items for a historical chart and %

Net revenues
Cost of sales (excludes amortization, presented below)	1.08B
Research and development	158.8M
Selling and marketing	223.6M
General and administrative	232.1M
Amortization	146.3M
Loss on asset sales and impairments
Total operating expenses	1.86B
Operating income	155.7M
Interest income	1.4M
Interest expense	-58.1M
Other income (expense)	-2.1M
Total other income (expense), net	-58.8M
Income before income taxes and noncontrolling interests	96.9M
Provision for income taxes	31.4M
Net income	65.5M
Loss attributable to noncontrolling interest	-100K
Net income attributable to common shareholders	65.6M
Basic	0.5
Diluted	0.49
Basic	132.5M
Diluted	134.4M

Entities mentioned with WPI

View All Entities